The role of immunotherapy in Guillain-Barré syndrome: understanding the mechanism of action
Guillain-Barré syndrome (GBS) is the most frequent cause of acute flaccid paralysis and, despite treatment, there continues to be an associated mortality and severe disability ranging from 9 to 17%. This article reviews the rationale behind the existing immunotherapy in GBS and discusses the future...
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artikel |
| Gepubliceerd in: |
Informa Healthcare
2011
|
| Onderwerpen: |